Quarterly Result5 Feb 2026, 12:00 pm
Vista Pharmaceuticals Ltd to Consider Q3 and Nine Months Financial Results on Feb 13, 2026
AI Summary
Vista Pharmaceuticals Ltd has announced that its Board of Directors will meet on February 13, 2026, to consider and approve the unaudited financial results for the quarter and nine months ended 31.12.2025. The meeting will also discuss the Limited Review Report for the same period. Any other business with the permission of the Chair will also be considered.
Key Highlights
- Vista Pharmaceuticals Ltd to consider Q3 and nine months financial results on Feb 13, 2026
- The meeting will discuss the unaudited financial results for the quarter and nine months ended 31.12.2025
- Limited Review Report for the same period will also be discussed
- The meeting will be held at the Registered office of the Company
- Any other business with the permission of the Chair will also be considered
Price Impact
More from VISTAPH